Biotech shake-up: Unity and Mammoth announce major layoffs amid strategic shifts
FierceBiotech - 05-May-2025Unity exits eye drug race, Mammoth tightens focus on CRISPR pipeline
Investments News
Stately Bio emerges with AI-powered window into living cells
Endpoints News - 01-May-2025AI startup decodes live cell behaviour using simple imaging and machine learning
A brighter path for Parkinson’s: light therapy device nears FDA finish line
Longevity Technology - 28-Apr-2025PhotoPharmics secures $6 million to advance its home-based Celeste device
Catalytic antibodies lose their champion
Fight Aging! - 23-Apr-2025Covalent Biosciences falters amid investor caution, patent expiry, and steep development costs
Biolinq secures $100m to launch needle-free glucose monitor
FierceBiotech - 22-Apr-2025Tracks glucose, activity, and sleep—offering a simpler option for people with Type 2 diabetes
Breakthrough drug targets liver regeneration with 21.5m boost
Longevity Technology - 17-Apr-2025HepaRegeniX advances trials for a novel liver regeneration therapy
AI alliance to redefine the future of ageing and therapeutics
Juvenescence - 16-Apr-2025M42 and Juvenescence join forces to accelerate precision medicine and longevity
Science corp secures major funding to restore sight with BCI tech
Longevity Technology - 15-Apr-2025A next-gen retinal implant offers new hope for vision loss from macular degeneration
New drug for Parkinson’s may keep symptoms under control with just weekly injections
Longevity Technology - 09-Apr-2025It avoids common delivery problems and enters Phase 1 trials in 2025
Switching genes, not sequences: the rise of epigenetic editing
Chemistry World - 09-Apr-2025Precision drugs use chemical tags to control genes without changing DNA
China’s RiboX beats rivals to launch first circular RNA clinical trial
Endpoints News - 04-Apr-2025A stealthy Shanghai startup pioneers a longer-lasting, safer alternative to mRNA and gene therapies
Isomorphic Labs secures $600m to supercharge AI drug discovery
FierceBiotech - 31-Mar-2025Backed by Nobel science, the Alphabet spinout speeds up AI drug development
Tribune Therapeutics secures 37m to tackle fibrosis at its source
Longevity Technology - 28-Mar-2025Scandinavian biotech targets fibrosis with novel scar-blocking therapies
23andMe files for bankruptcy after data breach and financial struggles
BBC - 24-Mar-2025Company is looking for a buyer, raising concerns about the security of customer DNA data
Bit.bio cuts 25% of staff as it shifts from therapy development to lab research
FierceBiotech - 19-Mar-2025Company aims to grow its product line and biotech partnerships
Mito Health raised $4 million to grow its AI-powered health platform
Longevity Technology - 18-Mar-2025It uses blood tests to find early health risks and gives personalised advice
AstraZeneca bets $1 billion on revolutionary cancer therapy
The Guardian - 17-Mar-2025AstraZeneca acquires EsoBiotec to revolutionize cell therapy with faster, more accessible treatments
Augustine Therapeutics raises $84.8m for safer neuro and metabolic drugs
Longevity Technology - 12-Mar-2025Clinical trials are beginning, backed by major investors like Novo Holdings
Hinge Health is filing for an IPO after cutting losses and boosting revenue
Endpoints News - 10-Mar-2025The IPO could mark a revival in digital health investments
Scientists plan to reproduce groundbreaking rejuvenation experiment in rats
Live Forever Club - 06-Mar-2025No donation too small to help extend Katcher's extracellular particles study
Trimtech secures $31m to tackle neurodegenerative diseases
Longevity Technology - 06-Mar-2025Targeted protein degradation tackles harmful aggregates while sparing healthy proteins
Tenaya raises $52.5m to push forward gene therapy trials
Longevity Technology - 05-Mar-2025The biotech firm accelerates clinical trials for TN-201 and TN-401, targeting genetic heart disease
Jupiter Neurosciences partners with Aquanova to develop longevity products
GlobeNewswire - 04-Mar-2025New collaboration aims to bring scientifically-backed solutions for ageing and healthspan
AbbVie joins the obesity drug race with $2.2b Gubra deal
Endpoints News - 03-Mar-2025The pharma giant bets on amylin therapy to enter the weight-loss market
Biograph: the elite longevity startup redefining preventive health
TechCrunch - 28-Feb-2025Backed by Peter Attia, this startup uses advanced diagnostics to optimize lifespan
Display all news
